Brokerages Set GlaxoSmithKline plc (GSK) Price Target at $1,668.38

Shares of GlaxoSmithKline plc (LON:GSK) have earned an average recommendation of “Hold” from the twenty-six analysts that are covering the stock. Three analysts have rated the stock with a sell recommendation, fifteen have issued a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is GBX 1,679.82 ($20.79).

A number of research analysts recently weighed in on the company. Credit Suisse Group AG reiterated a “neutral” rating and issued a GBX 1,800 ($22.28) target price on shares of GlaxoSmithKline plc in a report on Thursday, July 14th. S&P Global Inc. set a GBX 1,650 ($20.42) price objective on GlaxoSmithKline plc and gave the stock a “neutral” rating in a research note on Wednesday, July 27th. Beaufort Securities restated a “buy” rating on shares of GlaxoSmithKline plc in a research note on Tuesday, June 21st. BNP Paribas restated a “neutral” rating on shares of GlaxoSmithKline plc in a research note on Friday, July 29th. Finally, Citigroup Inc. set a GBX 1,800 ($22.28) price objective on GlaxoSmithKline plc and gave the stock a “buy” rating in a research note on Thursday, September 29th.

GlaxoSmithKline plc (LON:GSK) opened at 1700.00 on Tuesday. The company’s 50-day moving average price is GBX 1,649.81 and its 200-day moving average price is GBX 1,561.10. The stock’s market cap is GBX 82.64 billion. GlaxoSmithKline plc has a 1-year low of GBX 1,277.25 and a 1-year high of GBX 1,745.56.

The company also recently declared a dividend, which was paid on Thursday, October 13th. Shareholders of record on Thursday, August 11th were paid a dividend of GBX 19 ($0.24) per share. This represents a yield of 1.12%. The ex-dividend date was Thursday, August 11th.

In other news, insider Witty,Sir Andrew P sold 10,000 shares of the firm’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($20.95), for a total transaction of £169,300 ($209,529.70). Also, insider Slaoui,Moncef acquired 28 shares of GlaxoSmithKline plc stock in a transaction dated Friday, August 12th. The shares were bought at an average cost of GBX 2,208 ($27.33) per share, with a total value of £618.24 ($765.15).

About GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Michael Jordan Gains Ground on Getting His Name Back
Michael Jordan Gains Ground on Getting His Name Back
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday


 
© 2006-2016 Ticker Report. Google+.